Delivery Order SPE2DB20D2014-SPE2DB25FB02N

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $38,534.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 19, 2024 with an ultimate completion date of April 22, 2024. The contract has no set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of PRIORIX VIALS medical product to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The fixed-price delivery order is valued at $24,395.00 and has a completion date of June 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $25,199.50, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 3, 2024. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of PRIORIX VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,047.88 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.62 firm fixed-price contract is for the supply of PRIORIX VIALS, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of PRIORIX VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,588.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 5, 2024. The contract has a ceiling value of $16,588.60 and an ultimate completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $20,065.50 for the supply of PRIORIX VIALS medical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 3, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.24 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of March 28, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award is for the supply of PRIORIX VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $48,790.00 and is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,715.40 firm-fixed-price delivery order is for the supply of PRIORIX VIALS, a medical product, with a period of performance through September 4, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB02N
    Delivery Order

This federal contract award is for the delivery of PRIORIX vials, a medical product, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $5,047.10 and an ultimate completion date of February 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/12/25, 9:46 AM